NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 932 coverTHE CLINICAL SCIENCE OF SUICIDE PREVENTION Copyright © 2001 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by Baldessarini, R. J.
Articles by Hennen, J.
Search for Related Content
PubMed
PubMed Citation
Articles by Baldessarini, R. J.
Articles by Hennen, J.
Annals of the New York Academy of Sciences 932:24-43 (2001)
© 2001 New York Academy of Sciences

Treating the Suicidal Patient with Bipolar Disorder

Reducing Suicide Risk with Lithium

Ross J. Baldessarinia, Leonardo Tondoa,b AND John Hennena

aInternational Consortium for Research on Bipolar Disorders; Department of Psychiatry & Neuroscience Program, Harvard Medical School, and the Bipolar & Psychotic Disorders Program, Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, Massachusetts 02478, USA
bDepartment of Psychology, University of Cagliari and Lucio Bini Stanley Foundation International Research Center, Cagliari, Sardinia

Address for correspondence: Dr. R.J. Baldessarini, Mailman Research Center, McLean Hospital, 115 Mill Street, Belmont, MA 02478. Voice: 617-855-3203; fax: 617-855-3479.
rjb{at}mclean.org)

Bipolar disorder is associated with increased mortality because of complications of commonly comorbid substance use and stress-sensitive medical disorders as well as accidents and very high rates of suicide. Long-term lithium treatment may be associated with reduced suicidal risk. We review and summarize findings that help to quantify relationships between the presence versus the absence of lithium maintenance and suicides or attempts in patients with bipolar or other major affective disorders. Results from 33 studies (1970-2000) yielded 13-fold lower rates of suicide and reported attempts during long-term lithium treatment than without it or after it was discontinued. Although greatly reduced, these rates remain above those estimated for the general population. Evidence for substantial, if incomplete, protection against suicide with lithium is supported by more compelling evidence than that for any other treatment provided for patients with mood disorders. Studies of commonly used, but incompletely evaluated, alternative treatments are required, and further protection against premature mortality can be anticipated with better protection against bipolar depression.

Key Words: Bipolar disorder • Depression • Lithium • Maintenance treatment • Manic-depressive disorders • Mortality rates • Suicide




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. S. Bauer, L. McBride, W. O. Williford, H. Glick, B. Kinosian, L. Altshuler, T. Beresford, A. M. Kilbourne, M. Sajatovic, and and Coauthors for the Cooperative Studies Program
Collaborative Care for Bipolar Disorder: Part I. Intervention and Implementation in a Randomized Effectiveness Trial
Psychiatr Serv, July 1, 2006; 57(7): 927 - 936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Valenstein, J. F. McCarthy, K. L. Austin, J. F. Greden, E. A. Young, and F. C. Blow
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
Am J Psychiatry, July 1, 2006; 163(7): 1219 - 1225.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
L. V. Kessing, L. Sondergard, K. Kvist, and P. K. Andersen
Suicide Risk in Patients Treated With Lithium
Arch Gen Psychiatry, August 1, 2005; 62(8): 860 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. G. Storosum, T. Wohlfarth, C. C. Gispen-de Wied, D. H. Linszen, B. P.R. Gersons, B. J. van Zwieten, and W. van den Brink
Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode
Am J Psychiatry, April 1, 2005; 162(4): 799 - 802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. S. Bauer and L. Mitchner
What Is a "Mood Stabilizer"? An Evidence-Based Response
Am J Psychiatry, January 1, 2004; 161(1): 3 - 18.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. K. Goodwin, B. Fireman, G. E. Simon, E. M. Hunkeler, J. Lee, and D. Revicki
Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
JAMA, September 17, 2003; 290(11): 1467 - 1473.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. J. Baldessarini and L. Tondo
Suicide Risk and Treatments for Patients With Bipolar Disorder
JAMA, September 17, 2003; 290(11): 1517 - 1519.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
P. Rucci, E. Frank, B. Kostelnik, A. Fagiolini, A. G. Mallinger, H. A. Swartz, M. E. Thase, L. Siegel, D. Wilson, and D. J. Kupfer
Suicide Attempts in Patients With Bipolar I Disorder During Acute and Maintenance Phases of Intensive Treatment With Pharmacotherapy and Adjunctive Psychotherapy
Am J Psychiatry, July 1, 2002; 159(7): 1160 - 1164.
[Abstract] [Full Text] [PDF]



footerLeft footerRight